Search

1 to 10 of 18
Sort by

Library Entry
SITC Webinar: I-O Highlights from ASCO 2019 - Recorded Webinar and Presentation Slides

On August 28, 2019, leading experts presented the latest advances in cancer immunotherapy emerging from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The webinar summarized key studies on the following topics: Biomarkers and checkpoint inhibitors Cellular therapies ...

2 attachments



Event
SITC Webinar: I-O Highlights from ASCO 2019

On Aug. 28, 2019, at Noon EDT, leading experts presented the latest advances in cancer immunotherapy emerging from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The webinar summarized key studies on the following topics: Biomarkers and checkpoint inhibitors Cellular...

 08-28-2019 | 12:00 - 13:00 ET



Web Page
Nursing Resources

Resources Designed for You. Nurses are critical to caring for cancer patients treated with immunotherapies. To ensure nurses are well equipped to respond to the needs of immunotherapy patients, SITC provides a number of resources specifically designed for the whole clinical care team: SITC...


Web Page
2019 WIN Leadership Institute

The Society for Immunotherapy of Cancer (SITC) is excited to announce the participants of the inaugural SITC Women in Cancer Immunotherapy Network (WIN) Leadership Institute, scheduled for Aug. 19-20, 2019, in Seattle, Wash. Kristin G. Anderson, PhD, Fred Hutchinson Cancer Research...


Library Entry
Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance

The risk of delayed autoimmunity occurring months or years after discontinuation of immunotherapy is frequently asserted in the literature. However, specific cases were rarely described until 2018, when a wave of reports surfaced. With expanding I-O indications in the adjuvant/neoadjuvant...


Library Entry
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?

A 61-year-old woman with a history of MG since 2005 was treated with azathioprine and pyridostigmine after thymectomy. In March 2016, she was diagnosed with MCC. Six months later the tumor had progressed to stage IV and metastases were detected in lymph nodes and the pancreas. The...



Event
SITC Cancer Immunotherapy Guidelines – Squamous Cell Carcinoma of the Head and Neck (HNSCC) Webinar

On July 24, 2019, leading experts in cancer immunotherapy presented an overview of the recently published SITC Cancer Immunotherapy Guidelines – Squamous Cell Carcinoma of the Head and Neck (HNSCC) at a live webinar. This FREE CME-, CNE-, CPE-certified webinar provided a chance for...

 07-24-2019 | 15:00 - 16:00 ET